Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 8, 2021

View Archived Issues

Urinary follistatin useful to monitor AKI severity

Researchers develop a cystic fibrosis-related diabetes murine model

Roche describes new cyclic GMP-AMP synthase inhibitors

Janssen identifies NLRP3 inflammasome inhibitors

New GTPase KRAS mutant inhibitors discovered at Incyte

Aryl hydrocarbon receptor modulators discovered at Dong-A ST

New JAK inhibitors patented by Gossamer Bio

Mineralocorticoid receptor antagonism ameliorates DKD phenotype in mice

Viking Therapeutics' dual GLP-1/GIP receptor agonists show potential in model of obesity

Novel UOX-iKO mouse as model of hyperuricemia

RBT-9 shown effective against BK virus infection

STAR-0215, a potent and long-acting MAb plasma kallikrein inhibitor for the treatment of HAE

Analysis of lung phenotype in rat CF models using flexiVent and X-ray velocimetry

Novel small molecule K+ secretagogue RDX-013 for treating hyperkalemia

Antibody discovery platform increases cancer immunotherapy targets

Studies of KL-11743 detail potential oncolytic activity of glucose transporter inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.